PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1464665
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1464665
Stem Cell Banking Market size was valued at USD 9,710.43 Million in 2023, expanding at a CAGR of 8.51% from 2024 to 2032.
Stem cell banking, also known as stem cell preservation or stem cell storage, refers to the process of collecting and storing stem cells for potential future medical use. Stem cells are undifferentiated cells that have the unique ability to develop into various types of cells in the body.Stem cell banking offers the opportunity to have precious cells cryogenically frozen for over 25 years, ready for future use should they be required. The processes involved are safe, non-invasive and risk free, and it is estimated that today 1 in 3 people will benefit from stem cell therapies at some point in life.
Stem Cell Banking Market- Market Dynamics
Increase in the global burden of major diseases and rise in the use of stem cell banking for curing badly damaged tissues are anticipated to propel the market growth.
Stem cell therapy offers hope as a potential treatment option for chronic conditions due to the regenerative abilities of stem cells. These remarkable cells can transform into various types of cells and repair damaged tissues, making them highly valuable in the field of regenerative medicine. The World Health Organization states that noncommunicable diseases (NCDs) are the primary causes of death and disease burden in the Region of the Americas. In 2019 alone, NCDs accounted for 5.8 million deaths, which is approximately 81% of the total deaths in the region. Chronic diseases also dominated the list of the top 10 leading causes of death globally in the same year. Moreover, ongoing advancements in stem cell research are continuously expanding the therapeutic potential of these cells. However, it is important to acknowledge that regulatory challenges may hinder the growth of the market.
Stem Cell Banking Market- Key Insights
As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 8.51% over the forecast period (2024-2032)
Based on product type segmentation, Placental Stem Cells (PSCs) was predicted to show maximum market share in the year 2023
Based on Service Type segmentation, Sample Preservation and Storage was the leading type in 2023
Based on Application segmentation, Personalized Storage was the leading type in 2023
On the basis of region, North America was the leading revenue generator in 2023
The Global Stem Cell Banking Market is segmented on the basis of Product Type, Service Type, Application, End-User, and Region.
The market is categorized into five groups based on the type of product: Placental Stem Cells (PSCs), Human Embryo-Derived Stem Cells (hESCs), Bone Marrow-Derived Stem Cells (BMSCs), Dental Pulp-Derived Stem Cells (DPSCS), Adipose Tissue-Derived Stem Cells (ADSCs), and Other. The dominant segment in the market is Placental Stem Cells (PSCs). These cells consist of mesenchymal stem cells (MSCs), hematopoietic stem cells (HSCs), and others. PSCs have attracted attention due to their unique characteristics, such as their high rate of proliferation, low immunogenicity, and ability to differentiate into multiple cell types.
The market is segmented into four main categories according to Service Type: Sample Collection and Transportation, Sample Processing, Sample Analysis, and Sample Preservation and Storage. Sample Preservation and Storage holds the largest share in the market. It plays a crucial role in the stem cell banking process by maintaining the long-term viability and functionality of stem cell samples for future therapeutic applications.
The market is categorized into two segments based on Application: Personalized Storage, Clinical and Research. Personalized Storage holds the majority share in the market. In the stem cell banking market, Personalized Storage pertains to the storage of stem cells for individual clients, offering customized services to cater to their specific requirements and preferences.
The market is segmented into two categories according to End-User: Hospitals, Speciality Clinics, and other establishments. Each segment of end-users possesses distinct needs and demands in relation to stem cell banking services.
Stem Cell Banking Market- Geographical Insights
Geographically, this market spans across North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further segmented by countries contributing to business activities. The market growth is predominantly driven by North America, attributed to the rising patient population and the continuous development of healthcare infrastructure in the region. The United States has the largest healthcare industry, with 784,626 businesses. In terms of employment, the healthcare & clinical trial data management system is the largest source of jobs in the country, employing one in every eight Americans. Many individuals are drawn to the health industry due to its above-average pay, with an average annual salary of USD 70,394 compared to the national average of USD47,060. Europe follows as the second largest region for market growth during the forecast period, owing to the high prevalence of chronic diseases and the expanding network of stem cell banking services.
Manufacturers differentiate themselves by offering unique features such as advanced storage technologies, additional services (e.g., genetic testing, immune cell banking), and personalized storage options tailored to individual client needs. Many stem cell banking companies expand their presence globally through partnerships, acquisitions, or establishing subsidiaries in new markets to tap into the growing demand for stem cell banking services. Companies invest in research and development to explore new applications of stem cells, improve storage techniques, and develop innovative therapies, aiming to stay ahead of competitors and meet evolving market demands.Key players continuously strive to strengthen their market position and meet the growing demand for stem cell banking services worldwide.
CooperSurgical, a renowned company in the field of fertility and women's health, revealed on September 8, 2023, that Cord Blood Registry (CBR) would play a significant role during the Cord Blood Connect conference scheduled from September 8th to 11th. This event serves as the yearly gathering of the Cord Blood Association.
On November 30, 2023, the Ministry of Health (MOH) issued a notification to Cordlife Group Limited (CGL) instructing them to cease the collection, testing, processing, and/or storage of any fresh cord blood and human tissues, as well as refrain from offering any new tests to patients, for a duration of up to six months. This directive is in effect until CGL submits their written representations to the ministry.
GLOBAL STEM CELL BANKING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
CBR Systems Inc.
China Cord Blood Corporation
Cordlife
Cordvida
Cryo-Cell International, Inc.
Cryo-Save AG (A Group of Esperite)
Cryoviva India
Lifecell
Smart Cells International Ltd
Viacord
Others